Cleared Traditional

K993635 - MDI SM/RNP TEST

K993635 is an FDA 510(k) clearance for MDI SM/RNP TEST, manufactured by Micro Detect, Inc.. The device is a Class 2 Immunology device with product code LJM cleared through the Traditional 510(k) pathway after a 75-day FDA review.

K993635 · Micro Detect, Inc. · Immunology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 2000
Decision
75d
Days
Class 2
Risk

K993635 is an FDA 510(k) clearance for the MDI SM/RNP TEST. Classified as Antinuclear Antibody (enzyme-labeled), Antigen, Controls (product code LJM), Class II - Special Controls.

Submitted by Micro Detect, Inc. (Tustin, US). The FDA issued a Cleared decision on January 10, 2000 after a review of 75 days - a notably fast clearance cycle.

This device falls under the Immunology FDA review panel, regulated under 21 CFR 866.5100 - the FDA immunology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Micro Detect, Inc. devices

FDA 510(k) Submission Details - K993635

510(k) Number K993635 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 27, 1999
Decision Date January 10, 2000
Days to Decision 75 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
30d faster than avg
Panel avg: 105d · This submission: 75d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LJM Device Classification - Class 2, Special Controls

Product Code LJM Antinuclear Antibody (enzyme-labeled), Antigen, Controls
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 866.5100
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Immunology devices follow this clearance model.

Regulatory Peers - LJM Antinuclear Antibody (enzyme-labeled), Antigen, Controls

All 68
Devices cleared under the same product code (LJM) and FDA review panel - the closest regulatory comparables to K993635.
EL-ANA PROFILES-2K1
K002559 · Theratest Laboratories, Inc. · Sep 2000
THE APTUS (AUTOMATED) APPLICATION OF THE TG IGG ELISA TEST SYSTEM. AN ENZYME LINKED IMMUNOSORBENT ASSAY (ELISA) FOR THE
K000879 · Zeus Scientific, Inc. · May 2000
THE APTUS (AUTOMATED APPLICATION OF THE TPO IGG ELISA TEST SYSTEM. AN ENZYME LINKED IMMUNOSORBENT ASSAY (ELISA) FOR THE
K000880 · Zeus Scientific, Inc. · May 2000
VARELISA RECOMBI ANA SCREEN EIA, MODELS 128 48/ 128 96
K993108 · Pharmacia & Upjohn Co. · Nov 1999
VARELISA RECOMBI ANA PROFILE
K993109 · Pharmacia & Upjohn Co. · Nov 1999
RELISA ANA SCREENING TEST SYSTEM, MODEL 7096-11
K992041 · Immuno Concepts, Inc. · Jul 1999